+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

JAK-STAT signaling pathway inhibition: a role for treatment of various dermatologic diseases



JAK-STAT signaling pathway inhibition: a role for treatment of various dermatologic diseases



Seminars in Cutaneous Medicine and Surgery 37(3): 198-208



Cutaneous inflammatory conditions such as psoriasis, atopic dermatitis, alopecia areata, vitiligo, and connective tissue diseases often remain a challenge to treat. Although there is an in-depth understanding of the clinical presentation of these diseases, much less is known regarding the pathophysiology. This has limited the effective treatment options for patients. A more detailed understanding of the pathogenesis of each disease will lead to newer targeted medications with less morbidity. Though there are different pathways involved in these diseases, the Janus Kinase (JAK)-Signal Transducer and Activator of Transcription proteins (STAT) signaling pathway is common to them all. Therefore, this review article endeavors to substantiate the immunopathology and clinical utility of the JAK inhibitors as treatments for different chronic inflammatory diseases of the skin.

(PDF emailed within 1 workday: $29.90)

Accession: 065827496

Download citation: RISBibTeXText

PMID: 30215638


Related references

JAK-STAT signaling pathway inhibition: a role for treatment of discoid lupus erythematosus and dermatomyositis. International Journal of Dermatology 57(8): 1007-1014, 2018

JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases. Vascular Pharmacology 43(5): 357-363, 2005

Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases. Clinical Immunology 189: 4-13, 2016

Constitutive association of Grb-2, key adaptor molecule of Ras signaling pathway, with STAT-5 or -6, transcription factors of Jak/STAT pathway, in hematopoietic and nonhematopoietic cell lines. Blood 94(10 SUPPL 1 PART 1): 473a, Nov 15, 1999

Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Current Drug Targets 9(5): 369-374, 2008

Constitutive association of ASH/GRB-2, key adaptor molecule of Ras signaling pathway, with STAT-5, transcription factor activated under JAK/STAT pathway, in hematopoietic and nonhematopoietic cell lines. Blood 92(10 SUPPL 1 PART 1-2): 577A, Nov 15, 1998

Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases. Current Signal Transduction Therapy 4(3): 201-221, 2009

The therapeutic effect of artesunate on rosacea through the inhibition of the JAK/STAT signaling pathway. Molecular Medicine Reports 17(6): 8385-8390, 2018

Role of the JAK/STAT signaling pathway in diabetic nephropathy. American Journal of Physiology. Renal Physiology 290(4): F762-F768, 2006

The role of JAK-STAT signaling pathway in cardiac remodeling. Sheng Li Ke Xue Jin Zhan 34(4): 365-368, 2004

The JAK-STAT signaling pathway and its role in oncogenesis, immunomodulation and development. Medicina Clinica 114(6): 227-234, 2000

Jak-Stat signaling pathway may play a role in the pathogenesis of cholesteatoma. American Journal of Otolaryngology 35(2): 130-136, 2014

The role of the Jak-Stat pathway in chemokine-mediated signaling in T lymphocytes. Signal Transduction 7(5-6): 427-438, 2007

Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome. Oncotarget 7(4): 4664-4679, 2016

Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis. Plos One 6(4): E18856, 2011